期刊文献+

hTERT片段真核表达质粒的构建 被引量:1

Construction of eukaryotic expression plasmid of human telomerase reverse transcriptase
下载PDF
导出
摘要 目的 :构建人端粒酶逆转录酶 (hTERT)片段的真核表达质粒 ,方法 :从肿瘤组织中提取总RNA ,采用RT PCR法扩增hTERT基因并克隆入PGEM TEasy载体中 ,然后再亚克隆于pcDNA3.1真核表达载体 ,用PCR扩增及限制性酶切法筛选重组真核表达质粒 ,并以DNA测序鉴定。结果 :PCR扩增及限制性酶切法证实重组真核表达质粒的构建成功。测序表明 ,hTERT基因片段与GenBank公布的相应基因同源性比较 ,核苷酸序列的同源性为 98.73% ,氨基酸序列的同源性为 99.6 8%。结论 :成功构建了hTERT真核表达质粒 。 Aim: To construct eukaryotic expression plasmid of human telomerase reverse transcriptase (hTERT). Methods: Genomic fragment of hTERT was amplified by RT PCR and inserted into the PGEM T Easy vector. The recombinant plasmid was cleaved by restriction endonuclease and subcloned into eukaryotic expression vector pcDNA3.1, and then transformed into the E.coli JM109. The recombinant plasmid was identified by PCR and restriction endonuclease .The genomic fragment of hTERT was determined and analyzed by DNA sequencing. Results: Eukaryotic expression plasmid of pcDNA3.1 hTERT was identified by and restriction endonuclease. hTERT fragment was compared with hTERT gene reported in GenBank for homology. The homology was 98.73% in nucleotide acid, and 99.68% in amino acid. Conclusion: The eukaryotic expression plasmid of hTERT has been successfully constructed. It will lay the foundation for anti tumor immunity therapy associated with hTERT.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第3期458-460,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 HTERT 克隆 表达载体 hTERT clone expression vector
  • 相关文献

参考文献9

  • 1Kim NW, Piatyszek MA, Prowse KR,et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266(5 193): 2 011
  • 2Paillard F. Immunosuppression mediated by tumor cells: A challenge for immunotherapeutic approaches. Hum Gene Ther,2000,11 ( 5 ) :657
  • 3White LK,Wright WE,Shay JW. Telomerase inhibitors. Trends Biotechnol, 2001,19(3) :114
  • 4Vonderheide RH,Schultze JL,Anderson KS, et al. Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res, 2001, 61(23):8 366
  • 5Vonder heide RH. Telomerase as a universal tumor-associated antigen for cancer immunotherapy. Oncogene ,2002, 21 ( 4 ):674
  • 6Kozak M. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNA. Mol Cell Bio1,1989,9( 11 ) :5 134
  • 7Schmidt EV, Christoph G, Zeller R, et al. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol, 1990, 10(8) :4 406
  • 8Carswell S, Alwine JC. Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol, 1989, 9(10) :4 248
  • 9庞建新,吴曙光.端粒酶逆转录酶(hTERT)的分子调节机制[J].第一军医大学学报,2001,21(2):156-157. 被引量:11

二级参考文献15

  • 1Scott K D,Cancer Res,2000年,60卷,537页
  • 2Gary A U,Int J Cancer,2000年,85卷,330页
  • 3Cong Y S,J Biol Chem,2000年,275卷,46期,3500页
  • 4Yin L,J Biol Chem,2000年,275卷,36671页
  • 5Sangtaek O,Oncogene,2000年,19卷,1485页
  • 6Chin L,Cell,1999年,97卷,527页
  • 7Junping L,FASEB J,1999年,13卷,2091页
  • 8Kang S S,J Biol Chem,1999年,274卷,13085页
  • 9Li H,Oncogene,1999年,18卷,6785页
  • 10Liu K,Proc Nat Acad Sci USA,1999年,96卷,5147页

共引文献10

同被引文献13

  • 1丁丽,赵国强,范清堂.B72和hTERT的真核表达载体的构建与鉴定[J].郑州大学学报(医学版),2006,41(3):460-463. 被引量:4
  • 2刘学强,杨辉,何家全,宋业纯,邱克军,王彬,吕胜青.hTERT转染神经干细胞端粒酶活性及hTERT mRNA检测[J].第三军医大学学报,2006,28(12):1292-1294. 被引量:7
  • 3奥斯伯 F M,布伦特 R,金斯顿 R E,等.精编分子生物学实验指南[M].颜子颖,王海林,译.北京:科学出版社,1998,512—514,366—373.
  • 4Bruder S P,Jaiswal N,Haynesworth S E.Growth kinetics,self-renewal,and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation[J].J Cell Biochem,1997,64(2):278-294.
  • 5Muniyappa K,Kironmai K M.Telomere structure,replication and length maintenance[J].Crit Rev Biochem Mol Biol,1998,33(4):297-336.
  • 6Bianco P,Riminucci M,Gronthos S,et al.Bone marrow stromal cells:nature,biology,and potential applications[J].Stem Cells,2001,19(1):180-192.
  • 7Mathon N F,Lloyd A C.Cell senescence and cancer[J].Nat Rev Cancer,2001,1(3):203-213.
  • 8Shay J W,Wright W E.Use of telomerase to create bioengineered tissues[J].Ann N Y Acad Sci,2005,1057:479-491.
  • 9Simonsen J L,Rosada C,Serakinci N,et al.Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells[J].Nat Biotechnol,2002,20(6):592-596.
  • 10Kim N W,Piatyszek M A,Prowse K R,et al.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266(5193):2011-2015.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部